AFG
CRL icon

Albion Financial Group’s Charles River Laboratories CRL Stock Holding History

Albion Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,368
Closed -$253K – 627
2024
Q4 		$253K Buy
1,368
+24
+2% +$4.62K 0.02% 172
2024
Q3 		$265K Buy
1,344
+1
+0.1% +$208 0.02% 163
2024
Q2 		$277K Sell
1,343
-55
-4% -$12.5K 0.02% 168
2024
Q1 		$379K Hold
1,398
– – 0.03% 149
2023
Q4 		$330K Hold
1,398
– – 0.03% 153
2023
Q3 		$274K Buy
1,398
+120
+9% +$24.6K 0.03% 152
2023
Q2 		$269K Sell
1,278
-50
-4% -$9.95K 0.02% 160
2023
Q1 		$268K Buy
1,328
+107
+9% +$24.2K 0.02% 155
2022
Q4 		$266K Sell
1,221
-10
-0.8% -$2.18K 0.03% 154
2022
Q3 		$242K Buy
1,231
+78
+7% +$16.8K 0.03% 156
2022
Q2 		$247K Sell
1,153
-220
-16% -$53.8K 0.02% 159
2022
Q1 		$390K Buy
1,373
+7
+0.5% +$2.16K 0.03% 164
2021
Q4 		$515K Sell
1,366
-39
-3% -$15.2K 0.04% 158
2021
Q3 		$580K Hold
1,405
– – 0.05% 144
2021
Q2 		$520K Buy
+1,405
New +$469K 0.05% 147
2020
Q4 		$347K Buy
1,390
+185
+15% +$44.1K 0.03% 157
2020
Q3 		$273K Buy
+1,205
New +$250K 0.03% 188

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Albion Financial Group's CRL Position: Q1 2025 in Review

Albion Financial Group sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,368 shares — an estimated $253K sold.

Albion Financial Group first reported a position in CRL in Q3 2020 and held it in 17 quarters. The position peaked at $580K in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Albion Financial Group reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Albion Financial Group sold 1,368 Charles River Laboratories shares in Q1 2025, an estimated $253K.
  • Albion Financial Group first reported a position in Charles River Laboratories in Q3 2020 and held it in 17 quarters.
  • Albion Financial Group's Charles River Laboratories position peaked at $580K in Q3 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Albion Financial Group's 13F filing for Q1 2025, filed 25 Apr 2025.